U.S. Food and Staples Retail Stock News

The sudden halt to a bipartisan housing bill and rising political tension around the SAVE America Act have thrown fresh uncertainty over the housing market, from homebuilders to institutional owners of single family rentals. For investors, that kind of policy limbo can reshape risk and opportunity faster than earnings reports do. This article looks at how that news flows through to the Homebuilders & Residential Construction screener and what that could mean for your portfolio decisions...

Sify Technologies (NasdaqCM:SIFY) is in focus after securing a $71 million sustainability linked loan from the International Finance Corporation to help fund two new data centers in Navi Mumbai and Chennai. See our latest analysis for Sify Technologies. At a share price of $14.84, Sify Technologies has pulled back in the short term, with the 1 day, 7 day and 30 day share price returns all in decline. However, the 90 day share price return of 11.5%, year to date share price return of 20.8% and...

The AI Infrastructure Stocks screener focuses on the hardware backbone that makes AI possible, at a time when global data, energy and inflation trends are front of mind for markets. With manufacturing PMIs firming in the US, services growth mixed in Europe and the UK, and central banks still wrestling with inflation, many investors are looking for business models tied to real assets and cash flow. This screener concentrates on companies that help build and run the specialized data centers,...

Why IDEAYA Biosciences Stock Is Back in Focus IDEAYA Biosciences (IDYA) is drawing renewed investor attention after enrolling the first patient in a Phase 1 trial that pairs IDE892 with IDE397 in MTAP-deleted solid tumors. The study centers on cancers such as non-small cell lung and pancreatic, where MTAP deletions are relatively common and no approved targeted therapies currently exist. This development is making IDEAYA Biosciences stock a focal point for investors watching early clinical...

Regulation is back in focus, and for many investors that can feel like a moving target. With new rules, shifting fiscal policy, changing interest rate expectations, and fresh economic data, some technology stocks appear better positioned than others to handle tighter oversight and evolving compliance demands. This Regulation-Resilient Technology Companies screener filters for large tech firms that already talk explicitly about regulation or compliance and that currently score well on measures...

Atmos Energy stock reacts to recent performance data Atmos Energy (ATO) has drawn investor attention after recent performance figures highlighted a mix of share price moves and fundamental data, prompting closer scrutiny of how its gas distribution and pipeline operations align with current expectations. See our latest analysis for Atmos Energy. The recent 1 day share price return of 0.88% has not offset the 30 day share price decline of 2.94% and 90 day decline of 5.78%. However, longer term...

FIGS (FIGS) has recently drawn investor attention after its shares moved sharply, with the stock up 6.8% in the latest session but down over the past week and month. That short term volatility is prompting closer scrutiny. See our latest analysis for FIGS. Looking past the latest move, FIGS has a 1-year total shareholder return of 108.13% alongside a 90-day share price return that declined 23.66%. This suggests recent momentum has cooled after a strong longer term run as investors reassess...

In recent days, Alkami Technology, Inc. highlighted the past success of its partnership with Landmark Credit Union, showing how Landmark accelerated its digital transformation and upgraded both retail and business member experiences using Alkami’s cloud-based platform. An important takeaway is that Landmark Credit Union scaled its commercial banking program using Alkami’s business and commercial capabilities, indicating how the platform can support deeper penetration into small-business and...

Guardant Health (GH) is back in focus after the U.S. Food and Drug Administration approved its Guardant360 CDx liquid biopsy as a companion diagnostic for Boehringer Ingelheim’s newly approved HERNEXEOS lung cancer therapy. See our latest analysis for Guardant Health. The recent FDA approval arrives as momentum in Guardant Health's stock has been strong, with a 90-day share price return of 55.58% and a 1-year total shareholder return of 174.69%. This indicates that investors are reassessing...

Kaspi.kz (NasdaqGS:KSPI) has drawn fresh attention after confirming a special cash dividend, with an ex dividend date tied to a payout of $1.74266 per share, together with a KZT 850 distribution per common share. See our latest analysis for Kaspi.kz. Against this backdrop, Kaspi.kz’s share price has moved to $86.0, with a 1 day share price return of 2.99% and a 7 day share price return of 3.28%. The 30 day share price return is down 6.05% and the 90 day share price return is 15.97%, alongside...

Jiayin Group (NasdaqGM:JFIN) has wrapped up FY 2025 with fourth quarter revenue of C¥1,090.2 million and basic EPS of C¥1.95, alongside trailing 12 month revenue of C¥6.2 billion and EPS of C¥29.41, all against a backdrop of 45.4% trailing earnings growth over the past year. Over recent periods the company has seen quarterly revenue move from C¥1,404.5 million and EPS of C¥5.18 in Q4 2024 to C¥1,775.6 million and EPS of C¥10.11 in Q1 2025, before reaching the latest Q4 print. This sets the...

If you are wondering whether Waters is priced fairly or if the stock leans more toward opportunity or caution, this article walks through the key valuation checks that may matter most to you. Waters recently closed at US$369.18, with returns of 3.4% over the last week, 7.8% over the last month, a decline of 3.3% year to date, and a 5.5% gain over the past year. This provides useful context before considering what the current price might imply. Recent coverage has described Waters as a mature...

EchoStar plans to change its Nasdaq stock ticker from SATS to ECHO. The new ticker is scheduled to take effect on June 24, 2026. The move is intended to align the NasdaqGS:SATS listing with EchoStar’s broader global connectivity focus. EchoStar sits at the intersection of satellite infrastructure and wider connectivity services, making the ticker shift more than a cosmetic update. As the company works to position itself as a broader global connectivity provider, the move away from a ticker...

How Box’s Recent Returns Set Up a Valuation Conversation Box has had a mixed share price record that sets the stage for a closer look at what investors may be paying for today versus what they are getting in terms of fundamentals and future potential. Over the last year, the stock is down 25.4%, with a year to date decline of 11.7% and a 30 day return that is down 1.7%, while the last 7 days show a 2.1% gain, which may catch the eye of investors watching for shifting sentiment. News flow...

Universal (UVV) is back in focus after its latest quarter showed higher year-over-year revenue and net profit, alongside a rise in institutional ownership as firms like BlackRock and Invesco increased their positions. See our latest analysis for Universal. At a share price of $52.84, Universal’s recent 1-month share price return is down 3.08%, while the 3-year total shareholder return of 27.92% points to steadier results over a longer period as institutions increase their exposure. If this...

Dave (DAVE) is back on investor radar after a series of earnings surprises over the past four quarters, supported by recent upward earnings estimate revisions that have contributed to a stronger tone in market sentiment. See our latest analysis for Dave. At a recent share price of $314.44, Dave has seen strong momentum, with a 1 day share price return of 10.01%, a 30 day share price return of 37.63% and a 1 year total shareholder return of 46.44%. The very large 3 year total shareholder...

Mueller Water Products, Inc. recently announced that Senior Vice President and Chief Human Resources Officer Todd P. Helms will leave the company effective September 1, 2026, then serve as a senior advisor under a consulting agreement through September 30, 2026 to support the transition. This leadership change comes as Mueller reports rising operating margins, strong earnings per share growth, and expanding free cash flow, underpinned by resilient demand for its water management and leak...

Atlantic International (NasdaqGM:ATLN) has just closed out FY 2025 with fourth quarter revenue of US$120.0 million and a basic EPS loss of US$0.49 per share, alongside a trailing twelve month EPS loss of US$1.08. Over recent quarters the company has reported revenue in a range from US$102.8 million to US$120.0 million, while quarterly EPS losses have moved between US$0.20 and US$0.49. This provides a clearer context for how margins are being pressured as management works through this loss...

Fox Corporation (NasdaqGS:FOXA) has entered a definitive agreement to acquire Roku, Inc. The deal brings together Fox’s traditional media assets with Roku’s connected TV and streaming platform. The agreement marks a material shift in Fox’s approach to digital distribution and audience reach. For investors following Fox, this agreement highlights how the company is positioning itself within video streaming and connected TV. Fox’s business has been rooted in news, sports, and entertainment...

Accenture (NYSE:ACN) has expanded its AI-driven industrial and automotive platform partnerships, including a new engineering partnership with Coretura, the Daimler Truck and Volvo joint venture. The company has launched Accenture Edge, a business segment focused on AI and digital transformation services for mid-market companies worldwide. Accenture is working on AI-powered digital twin projects for large industrial and consumer goods clients, including Unilever. These moves come as investors...

With the Federal Reserve holding rates at 4.25-4.50% and hinting that borrowing costs could stay higher for longer, income investors are once again paying close attention to dependable dividend payers. Elevated yields on cash and bonds are raising the bar for equity income, while inflation and a stronger dollar are testing weaker balance sheets. This article looks at 3 dividend stocks from a high-quality screener that appear closely tied to these macro shifts, and explains how their...

Qualcomm just put a bold marker down in AI and data center technology, lifting its 2029 non-handset revenue target to $40b and outlining fresh ambitions in data center CPUs and AI software. When a company of Qualcomm’s size resets expectations and lands a customer like Meta for its new Dragonfly C1000 chip, it can reshape how investors look at related stocks. This article walks through 3 stocks from an AI and data center screener that are closely tied to these developments, helping you...

Why HubSpot Stock Is Back in Focus After New Governance Move HubSpot (HUBS) has returned to investor focus after shareholders approved a non binding proposal that would let investors owning at least 10% of the stock call a special meeting. This governance shift comes alongside new product and partner developments. Together, these factors provide fresh context for thinking about HubSpot’s valuation, risk profile, and long term role in customer relationship management software. See our latest...

U.S. Federal Trade Commission grants early termination of the Hart-Scott-Rodino waiting period for Catalyst Pharmaceuticals' planned merger with Angelini Pharma. The early termination advances regulatory review for the transaction, which still requires shareholder approval. The merger is currently expected to close in the third quarter of 2026, subject to remaining conditions. Catalyst Pharmaceuticals, listed as NasdaqCM:CPRX, focuses on treatments for rare neurological and epileptic...